A new tally finds that nearly half of the U.S. adult population might be eligible to take semaglutide to battle obesity, ...
With advancements in technology, researchers say people with diabetes can easily access health data and plan for the ...
For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study ...
A University of Florida study finds that people with diabetes who participate in telehealth doctor visits report the same ...
This study links rare genetic variants to type 2 diabetes risk, emphasizing their role in monogenic diabetes and potential ...